• ABOUT JSLR
• DIRECTORS AND COMMITTEES
• SECRETARIAT AND MEMBERSHIP

• AIMS AND SCOPE
• ONLINE SUBMISSION
• ARTICLE TYPES
• MANUSCRIPT PREPARATION
• EDITORIAL PROCESS
• POST-ACCEPTANCE
  　　AND TECHNICAL INFORMATION
• EDITORIAL POLICIES
• OPEN ACCESS AND COPYRIGHT
• ADVERTISING POLICY
• CONTACT INFORMATION
• ARCHIVES
• EDITORIAL BOARD

OFFICIAL JOURNAL OF THE JSLR > ARCHIVES > Volume 63

• Volume 63(2023)

  ■Commentary

  Number 4

  ---

  Highlights: Follicular lymphoma
  Recent advances of the pathobiology and treatment of follicular lymphoma and challenging to the new therapeutic avenues

  Katsuyoshi Takata

  ■Review Article

  Number 3

  ---

  Follicular lymphoma microenvironment: insights provided by single-cell analysis

  Yoshiaki Abe

  The pathobiology of follicular lymphoma

  Joaquim Carreras

  Number 2

  ---

  Diagnostic approach for classic Hodgkin lymphoma in small samples with an emphasis on PD-L1 expression and EBV harboring in tumor cells: a brief review from morphology to biology

  Taishi Takahara, Ayako Sakakibara, Yuta Tsuyuki, Akira Satou, Seiichi Kato, Shigeo Nakamura

  Precursory or early lesions of follicular lymphoma: clinical features, pathology, and genetics

  Naoki Oishi

  Number 1

  ---

  Prognostic indices for peripheral T-cell lymphoma - not otherwise specified and adult T-cell leukemia/lymphoma: From past to future

  Kenji Ishitsuka

  Histologic transformation of follicular lymphoma: pathologists’ viewpoint

  Akiko Miyagi Maeshima

  ■Original Article

  Number 4

  ---

  Clinico-pathological profile of patients with plasma cell neoplasms with special reference to bone marrow fibrosis and amyloid deposition

  Narasimhapriyan Kannan, Jasmita Dass, Sahitya Dangudubiyyam, Ganesh Kumar Viswanathan,
  Mukul Aggarwal, Pradeep Kumar, Rishi Dhawan, Tulika Seth, Manoranjan Mahapatra

  Treatment patterns in patients with chronic lymphocytic leukemia/small lymphocytic lymphoma post covalent Bruton tyrosine kinase inhibitor treatment: a Japanese claims database study

  Dai Maruyama, Chaochen Wang , Yoshinori Tanizawa, Zhihong Cai, Yujing Huang,
  Masaomi Tajimi, Shigeru Kusumoto

  Evidence for distinct mechanisms of immune suppression in EBV-positive and EBV-negative Hodgkin lymphoma

  Makka Adam, Yonas Bekuretsion, Amha Gebremedhin, Anna Kwiecinska, Rawleigh Howe,
  Beyene Petros, Mats Jerkeman

  Number 3

  ---

  Prognostic impact of miR-125b and miR-155b and their relationship with MYC and TP53 in diffuse large B-cell lymphoma: cell-of-origin classification matters

  Eduardo Henrique Cunha Neves Filho, Stella Barbanti Zancheta, Paulo Goberlânio de Barros Silva,
  Rommel Mario Rodríguez Burbano, Silvia Helena Barem Rabenhorsti

  Impact of single versus multiple spliceosome mutations on myelodysplastic syndrome

  Pakasticali Nagehan, Mirza Sabbir, Jinming Song, Hussaini Mohammad

  Number 2

  ---

  The clinical impact of the ratio of C-reactive protein to albumin (CAR) in patients with acute- and lymphoma-type adult T-cell leukemia-lymphoma (ATL)

  Noriaki Kawano, Hidemi Shimonodan, Yuri Nagahiro, Shuro Yoshida, Takuro Kuriyama,
  Ken Takigawa, Taro Tochigi, Takashi Nakaike, Shigeyoshi Makino, Kiyoshi Yamashita,
  Kousuke Marutsuka, Hidenobu Ochiai, Yasuo Mori, Kazuya Shimoda, Kouichi Ohshima,
  Koichi Mashiba, Ikuo Kikuchi

  Role of TGF-beta1 and TNF-alpha1 produced by neoplastic cells in the pathogenesis of fibrosis in patients with hematologic neoplasms

  Haruko Takizawa, Yoshihiko Araki, Maki Fujishiro, Shigeki Tomita, Satsuki Kishikawa,
  Akane Hashizume, Toru Mitsumori, Hideaki Nitta, Hiroko Iizuka-Honma, Tomohiro Sawada,
  Mitsuo Okubo, Yasunobu Sekiguchi, Miki Ando, Masaaki Noguchi

  EBV-positive mucocutaneous ulcer arising in methotrexate-treated rheumatoid arthritis patients: a clinicopathological study of 12 cases with analysis of PD-L1 expression

  Keisuke Sawada, Shuji Momose , Yosuke Iijima, Takumi Takahashi, Takahiro Kaneko,
  Wataru Yamamoto, Takahisa Yamashita, Morihiro Higashi, Masahiro Kizaki, Jun-ichi Tamaru

  Long-term effectiveness and safety of high dose chemotherapy followed by autologous stem cell transplantation in daily practice in patients with diffuse large B-cell lymphoma

  Takahiro Haeno, Shinya Rai , Yoshiaki Miyake, Maiko Inoue, Ko Fujimoto, Aki Fujii,
  Yoshio Iwata, Shuji Minamoto, Takahide Taniguchi, Hiroaki Kakutani, Hiroaki Inoue,
  Takahiro Kumode, Kentaro Serizawa, Yasuhiro Taniguchi, Chikara Hirase, Yasuyoshi Morita,
  Hirokazu Tanaka, Yoichi Tatsumi, Takashi Ashida, Itaru Matsumura

  Japanese subgroup analysis in the Asian phase II study of darinaparsin in patients with relapsed or refractory peripheral T-cell lymphoma

  Eiju Negoro, Takahiro Yamauchi, Noriko Fukuhara, Kazuhito Yamamoto, Toshiki Uchida,
  Koji Izutsu, Dai Maruyama, Yasuhito Terui, Hideaki Nakajima, Kiyoshi Ando, Youko Suehiro,
  Ilseung Choi, Nobuhiro Kanemura, Nobuhiko Nakamura, Go Yamamoto, Yoshinobu Maeda,
  Hirohiko Shibayama, Fumiko Nagahama, Yusuke Sonehara, Hirokazu Nagai, Hwei-Fang Tien,
  Yok-Lam Kwong, Won-Seog Kim, Kensei Tobinai

  High-grade B-cell lymphoma with 11q aberrations: A single-center study

  Shoki Yamada, Yuka Oka, Moe Muramatsu, Yuko Hashimoto

  Number 1

  ---

  Real-world efficacy of DA-EPOCH-R/HD-MTX regimen in CD5-positive diffuse large B cell lymphoma: a single-institute analysis

  Kohtaro Toyama, Keita Nakayama, Sachie Terasaki, Ikuko Matsumura, Shuhei Kanaya,
  Hiromasa Iino, Hiroyuki Noguchi, Kenichi Tahara, Takatomo Yoshida, Akio Saito

  Comparison of serum sIL-2R and LDH levels in patients with intravascular large B-cell lymphoma and patients with advanced stage diffuse large B-cell lymphoma

  Yuki Hirami, Midori Filiz Nishimura, Tomohiro Urata, Michiko Morimoto, Yukina Maekawa,
  Tadashi Yoshino, Yoshito Nishimura, Yasuharu Sato

  ■Case report

  Number 4

  ---

  RUNX1 rearrangement in mature B-cell acute lymphoblastic leukemia with non-L3 morphology

  Katsuya Yamamoto, Akihito Kitao, Marika Watanabe, Hiroshi Kanehira, Miki Joyce,
  Yuri Hirakawa, Sakuya Matsumoto, Kimikazu Yakushijin, Hironobu Minami

  Sutimlimab suppresses SARS-CoV-2 mRNA vaccine-induced hemolytic crisis in a patient with cold agglutinin disease

  Hiroki Kobayashi, Tomoki Ouchi, Wataru Kitamura, Shoji Asakura, Tomofumi Yano,
  Hiromasa Takeda, Yoshiyuki Tokuda, Tadashi Yoshino, Yoshinobu Maeda

  Methotrexate-induced subacute myelopathy: a serious but treatable complication

  Takashi Miyoshi, Tadakazu Kondo, Momoko Nishikori, Toshio Kitawaki, Katsuya Kobayashi,
  Masakazu Fujimoto, Noriyoshi Yoshinaga, Satoshi Oka, Kohsuke Asagoe, Shinsaku Imashuku,
  Akifumi Takaori-Kondo

  Coincidence of de novo T-lymphoblastic lymphoma and cutaneous gamma/delta peripheral T-cell lymphoma

  Tsugumi Satoh, Hidekazu Kayano, Mika Kohri, Ken Tanae, Chie Asou, Naoki Takahashi,
  Kunihiro Tsukasaki, Masanori Yasuda

  Number 3

  ---

  A case of classic Hodgkin lymphoma arising after remission of methotrexate-associated follicular lymphoma

  Yayoi Ueda, Takehiro Tanaka, Shoji Asakura, Tomofumi Yano

  Diffuse large B-cell lymphoma with composite germinal center and non-germinal center types: A report of two cases

  Ayumi Sugitani, Suguru Fukuhara, Maki Shibata, Ryosuke Ichihara, Haruhi Furukawa,
  Akiko Miyagi Maeshima

  Acalabrutinib and steroid for autoimmune thrombocytopenia due to relapsed chronic lymphocytic leukemia with severe bone marrow infiltration

  Takashi Oyama, Megumi Yasunaga, Masahiro Jona, Masako Nishikawa, Yutaka Yatomi,
  Akira Honda, Hiroaki Maki, Ken Morita, Yosuke Masamoto, Mineo Kurokawa

  Acute promyelocytic leukemia masquerading as myeloid maturation arrest- A Case report

  Narasimhapriyan Kannan, Jasmita Dass, Ganesh Kumar Viswanathan, Preeti Khokhar,
  Mukul Aggarwal

  Number 2

  ---

  Concurrent development of small lymphocytic lymphoma and lung cancer: A report of two cases and a review of the literature

  Kensuke Nakao, Momoko Nishikori, Masakazu Fujimoto, Hiroshi Arima, Hironori Haga,
  Akifumi Takaori-Kondo

  Myeloid sarcoma incidentally found in lymph nodes dissected for advanced gastric cancer

  Rin Yamada, Tomoko Miyata-Takata, Ryo Tanaka, Yoshihiro Komohara , Katsuyoshi Takata

  Number 1

  ---

  Development of rapidly fatal TAFRO syndrome-like features in a patient with essential thrombocythemia

  Hiroko Iizuka-Honma, Haruko Takizawa, Hideaki Nitta, Toru Mitsumori, Masaaki Noguchi

  Benefit of prednisolone alone in nodal peripheral T-cell lymphoma with T follicular helper phenotype

  Wataru Kitamura, Hiroki Kobayashi, Tomohiro Urata, Yumiko Sato, Yusuke Naoi,
  Tadashi Yoshino, Yoshinobu Maeda, Shoichi Kuyama

  Development of a human herpesvirus 8-negative effusion-based lymphoma during treatment with dasatinib for chronic myeloid leukemia

  Takahiro Suyama, Masao Hagihara, Naruaki Matsui, Rie Irie, Yoshiyuki Osamura, Tetsuo Sakai,
  Shouichi Watanabe, Shintarou Umemoto, Naoki Miyao

  Enhanced PD-L1 expression on tumor cells in primary CD30-positive cutaneous large T-cell lymphoma: a report of lymph node lesions of four cases

  Emiko Takahashi, Hiroshi Imai, Yuta Tsuyuki, Natsuki Taniguchi, Yasunori Kogure,
  Keisuke Kataoka, Takashi Tsuchida, Satoshi Baba, Toyonori Tsuzuki, Takatoshi Shimauchi,
  Shigeo Nakamura

  ■Short Communication

  Number 4

  ---

  Use of R-mini-CHP in combination with polatuzumab vedotin (pola-R-mini-CHP) as the primary treatment in ≥80-year-old cases with diffuse large B-cell lymphoma

  Yasunobu Sekiguchi , Hiroki Tsutsumi, Ayumi Gomyo, Masahisa Kudo, Yoshie Iizaki,
  Nobuo Maseki, Machiko Kawamura, Kazuhiko Kobayashi, Yu Nishimura, Hiroaki Kanda,
  Hideaki Nitta, Masaaki Noguchi, Hirofumi Kobayashi

  Number 3

  ---

  Infections associated with bendamustine and anti-CD20 antibody in untreated follicular lymphoma: a real-world study

  Masuho Saburi, Kazuki Okuhiro, Natsumi Yoshida, Takami Haruyama, Yui Moroga, Yuka Yanai,
  Kazuhito Itani, Kuniko Takano, Shuhei Honda, Keiji Ono, Manami Iwanaga, Hitohiro Sasaki,
  Miyuki Abe, Kazuhiro Kohno, Toshiyuki Nakayama, Eiichi Ohtsuka, Masao Ogata

  Poor clinical outcome of relapsed/refractory diffuse large B-cell lymphoma with MYC translocation treated with polatuzumab vedotin, bendamustine, and rituximab

  Masuho Saburi, Masanori Sakata, Yousuke Kodama, Keiichi Uraisami, Hiroyuki Takata,
  Yasuhiko Miyazaki, Junpei Wada, Shogo Urabe, Eiichi Ohtsuka

  Treatment outcomes of mantle cell lymphoma in real-world practice: analysis of forty-one patients

  Masuho Saburi, Yosuke Kodama, Keiichi Uraisami, Hiroyuki Takata, Yasuhiko Miyazaki,
  Takumi Nishikawa, Hitohiro Sasaki, Miyuki Abe, Kazuhiro Kohno, Junpei Wada, Shogo Urabe,
  Yoshiyuki Kondo, Toshiyuki Nakayama, Eiichi Ohtsuka

  ■Letter to the Editor

  Number 4

  ---

  Significant response of patients with transformed follicular lymphoma with rapid disease progression to CAR-T therapy

  Taichi Hirano, Hiro Tatetsu, Shikiko Ueno, Takafumi Shichijo, Shota Furukawa,
  Mizuho Tsujihashi, Toshikazu Miyakawa, Shinya Shiraishi, Yusuke Higuchi, Mitsuhiro Uchiba,
  Jun-ichirou Yasunaga, Kisato Nosaka, Masao Matsuoka

  C/EBP homogenous protein-induced Apoptosis in Endoplasmic Reticulum stress has been implicated in Kikuchi–Fujimoto Disease

  Shigeyuki Asano, Kazuki Yamazaki, Kikuo Mori, Yuko Hashimoto, Satoshi Kawana,
  Hiroko Sato, Hiroyuki Naito, Koji Shikano, Yoichiro Sogame, Makoto Kashimura

  Number 3

  ---

  Kikuchi-Fujimoto disease following COVID-19 in a 32-year-old woman

  Rin Yamada, Yoshihiro Komohara, Hiroshi Yoshii